50
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths : A Systematic Review

      other

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Data suggest that impacts of COVID-19 differ among U.S. racial/ethnic groups. This systematic review evaluates racial/ethnic disparities in SARS-CoV-2 infection rates and COVID-19 outcomes, factors contributing to disparities, and interventions to reduce them.

          Abstract

          Background:

          Data suggest that the effects of coronavirus disease 2019 (COVID-19) differ among U.S. racial/ethnic groups.

          Purpose:

          To evaluate racial/ethnic disparities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and COVID-19 outcomes, factors contributing to disparities, and interventions to reduce them. (PROSPERO: CRD42020187078)

          Data Sources:

          English-language articles in MEDLINE, PsycINFO, CINAHL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus, searched from inception through 31 August 2020. Gray literature sources were searched through 2 November 2020.

          Study Selection:

          Observational studies examining SARS-CoV-2 infections, hospitalizations, or deaths by race/ethnicity in U.S. settings.

          Data Extraction:

          Single-reviewer abstraction confirmed by a second reviewer; independent dual-reviewer assessment of quality and strength of evidence.

          Data Synthesis:

          37 mostly fair-quality cohort and cross-sectional studies, 15 mostly good-quality ecological studies, and data from the Centers for Disease Control and Prevention and APM Research Lab were included. African American/Black and Hispanic populations experience disproportionately higher rates of SARS-CoV-2 infection, hospitalization, and COVID-19–related mortality compared with non-Hispanic White populations, but not higher case-fatality rates (mostly reported as in-hospital mortality) (moderate- to high-strength evidence). Asian populations experience similar outcomes to non-Hispanic White populations (low-strength evidence). Outcomes for other racial/ethnic groups have been insufficiently studied. Health care access and exposure factors may underlie the observed disparities more than susceptibility due to comorbid conditions (low-strength evidence).

          Limitations:

          Selection bias, missing race/ethnicity data, and incomplete outcome assessments in cohort and cross-sectional studies must be considered. In addition, adjustment for key demographic covariates was lacking in ecological studies.

          Conclusion:

          African American/Black and Hispanic populations experience disproportionately higher rates of SARS-CoV-2 infection and COVID-19–related mortality but similar rates of case fatality. Differences in health care access and exposure risk may be driving higher infection and mortality rates.

          Primary Funding Source:

          Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: not found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

            Abstract Objective To describe outcomes of people admitted to hospital with coronavirus disease 2019 (covid-19) in the United States, and the clinical and laboratory characteristics associated with severity of illness. Design Prospective cohort study. Setting Single academic medical center in New York City and Long Island. Participants 5279 patients with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection between 1 March 2020 and 8 April 2020. The final date of follow up was 5 May 2020. Main outcome measures Outcomes were admission to hospital, critical illness (intensive care, mechanical ventilation, discharge to hospice care, or death), and discharge to hospice care or death. Predictors included patient characteristics, medical history, vital signs, and laboratory results. Multivariable logistic regression was conducted to identify risk factors for adverse outcomes, and competing risk survival analysis for mortality. Results Of 11 544 people tested for SARS-Cov-2, 5566 (48.2%) were positive. After exclusions, 5279 were included. 2741 of these 5279 (51.9%) were admitted to hospital, of whom 1904 (69.5%) were discharged alive without hospice care and 665 (24.3%) were discharged to hospice care or died. Of 647 (23.6%) patients requiring mechanical ventilation, 391 (60.4%) died and 170 (26.2%) were extubated or discharged. The strongest risk for hospital admission was associated with age, with an odds ratio of >2 for all age groups older than 44 years and 37.9 (95% confidence interval 26.1 to 56.0) for ages 75 years and older. Other risks were heart failure (4.4, 2.6 to 8.0), male sex (2.8, 2.4 to 3.2), chronic kidney disease (2.6, 1.9 to 3.6), and any increase in body mass index (BMI) (eg, for BMI >40: 2.5, 1.8 to 3.4). The strongest risks for critical illness besides age were associated with heart failure (1.9, 1.4 to 2.5), BMI >40 (1.5, 1.0 to 2.2), and male sex (1.5, 1.3 to 1.8). Admission oxygen saturation of 1 (4.8, 2.1 to 10.9), C reactive protein level >200 (5.1, 2.8 to 9.2), and D-dimer level >2500 (3.9, 2.6 to 6.0) were, however, more strongly associated with critical illness than age or comorbidities. Risk of critical illness decreased significantly over the study period. Similar associations were found for mortality alone. Conclusions Age and comorbidities were found to be strong predictors of hospital admission and to a lesser extent of critical illness and mortality in people with covid-19; however, impairment of oxygen on admission and markers of inflammation were most strongly associated with critical illness and mortality. Outcomes seem to be improving over time, potentially suggesting improvements in care.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              COVID-19 and African Americans

                Bookmark

                Author and article information

                Journal
                Ann Intern Med
                Ann Intern Med
                aim
                Annals of Internal Medicine
                American College of Physicians
                0003-4819
                1539-3704
                1 December 2020
                : M20-6306
                Affiliations
                [1 ]VA Evidence Synthesis Program, VA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (K.M., K.K.K., S.S., D.K.)
                [2 ]VA Evidence Synthesis Program, VA Portland Health Care System, Portland, Oregon (C.K.A., S.Y., J.A., S.V.)
                [3 ]Social Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland (S.M.A.)
                [4 ]Oregon Health & Science University, Portland, Oregon (H.S., M.R.)
                [5 ]Oregon Health & Science University–Portland State University School of Public Health, Portland, Oregon (M.S.)
                Author notes
                Acknowledgment: The authors thank staff at the VHA Office of Health Equity for their input on the scope of this review.
                Disclaimer: The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the US Government.

                Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-6306.

                Financial Support: By the Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development.
                Reproducible Research Statement: Study protocol: Available at PROSPERO (registration: CRD42020187078). Statistical code and data set: Not applicable.
                Corresponding Author: Katherine Mackey, MD, MPP, VA Evidence Synthesis Program, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Road, P3MED, Portland, OR 97239; e-mail, katherine.mackey@ 123456va.gov .
                Current Author Addresses: Dr. Mackey: VA Evidence Synthesis Program, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Road, P3MED, Portland, OR 97239.
                Ms. Ayers; Drs. Kondo and Saha; Ms. Young; Ms. Anderson; Ms. Veazie; and Dr. Kansagara: VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Road, Mail Code R&D 71, Portland, OR 97239.
                Drs. Advani: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007.
                Drs. Rusek and Spencer: Oregon Health & Science University, Department of Medicine, 3181 SW Sam Jackson Park Road, Portland, OR 97239.
                Ms. Smith: Oregon Health & Science University–Portland State University School of Public Health, 840 SW Gaines Street, Hall Room 230, Portland, OR 97239.
                Author Contributions: Conception and design: K. Mackey, C.K. Ayers, K.K. Kondo, S. Saha, D. Kansagara.
                Analysis and interpretation of the data: K. Mackey, C.K. Ayers, K.K. Kondo, S. Saha, S.M. Advani, S. Young, H. Spencer, M. Rusek, J. Anderson, D. Kansagara.
                Drafting of the article: K. Mackey, C.K. Ayers, S.M. Advani, D. Kansagara.
                Critical revision for important intellectual content: K. Mackey, C.K. Ayers, K.K. Kondo, S. Saha, S.M. Advani, S. Young, D. Kansagara.
                Final approval of the article: K. Mackey, C.K. Ayers, K.K. Kondo, S. Saha, S.M. Advani, S. Young, H. Spencer, M. Rusek, J. Anderson, S. Veazie, M. Smith, D. Kansagara.
                Provision of study materials or patients: M.S. Rusek.
                Statistical expertise: S.M Advani.
                Administrative, technical, or logistic support: C.K. Ayers, K.K. Kondo, S. Young.
                Collection and assembly of data: K. Mackey, C.K. Ayers, K.K. Kondo, S.M Advani, S. Young, H. Spencer, M. Rusek, J. Anderson, S. Veazie, M. Smith, D. Kansagara.
                Author information
                https://orcid.org/0000-0003-4749-5664
                https://orcid.org/0000-0002-0022-9257
                https://orcid.org/0000-0002-4635-5056
                https://orcid.org/0000-0002-5710-1836
                https://orcid.org/0000-0003-4470-1020
                Article
                aim-olf-M206306
                10.7326/M20-6306
                7772883
                33253040
                cf9597e6-0719-47fd-8ce7-9d07ab449619
                Copyright @ 2020

                This article is made available via the PMC Open Access Subset for unrestricted re-use for research, analyses, and text and data mining through PubMed Central. Acknowledgement of the original source shall include a notice similar to the following: "© 2020 American College of Physicians. Some rights reserved. This work permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited." These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Categories
                Reviews
                early, Currently Online First
                coronavirus, Coronavirus Disease 2019 (COVID-19)
                poc-eligible, POC Eligible
                3122457, COVID-19
                2357, Health care providers
                11279, SARS coronavirus
                9715, Patients
                6354, Upper respiratory tract infections
                1541398, Pulmonary diseases
                3282, Infectious diseases
                8910, Epidemiology
                7245, Lungs

                Comments

                Comment on this article